Observational studyMedicine2016
Trastuzumab improves locoregional control in HER2-positive breast cancer patients following adjuvant radiotherapy.
Lu Cao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this paperpooled itcites it